SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 171 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,162,000 | -74.2% | 199,945 | -66.8% | 0.01% | -75.0% |
| Q4 2021 | $4,511,000 | -18.0% | 601,521 | -1.5% | 0.02% | -17.2% |
| Q3 2021 | $5,501,000 | -24.2% | 610,590 | +0.8% | 0.03% | -25.6% |
| Q2 2021 | $7,253,000 | -8.9% | 605,897 | -4.7% | 0.04% | -13.3% |
| Q1 2021 | $7,964,000 | -21.8% | 635,568 | -2.6% | 0.04% | -25.0% |
| Q4 2020 | $10,183,000 | +122.1% | 652,531 | +34.5% | 0.06% | +106.9% |
| Q3 2020 | $4,584,000 | +9.5% | 485,042 | +3.8% | 0.03% | +7.4% |
| Q2 2020 | $4,185,000 | +81.1% | 467,087 | +28.8% | 0.03% | +68.8% |
| Q1 2020 | $2,311,000 | +64.4% | 362,761 | +115.9% | 0.02% | +166.7% |
| Q4 2019 | $1,406,000 | +5758.3% | 168,003 | +6138.5% | 0.01% | – |
| Q2 2017 | $24,000 | -11.1% | 2,693 | -39.7% | 0.00% | – |
| Q1 2016 | $27,000 | -34.1% | 4,469 | 0.0% | 0.00% | – |
| Q4 2015 | $41,000 | +86.4% | 4,469 | +12.5% | 0.00% | – |
| Q3 2015 | $22,000 | -89.1% | 3,972 | -69.0% | 0.00% | -100.0% |
| Q1 2015 | $201,000 | – | 12,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |